Therapeutic effect prediction method in the treatment of atopic dermatitis using mesenchymal stem cells

摘要

A patient with atopic dermatitis treated with mesenchymal stem cell transplantation is treated as a target patient before and after treatment, and the mesenchymal stem cells are administered only to patients who are judged to be appropriate for treatment of mesenchymal stem cells In order to support the above, for example, a judgment technique as a companion diagnosis method and a method for establishing the criterion and a diagnostic kit for this determination are provided.In the blood sample collected from the objectMeasuring the concentration of glucosamine or mannosamine andThe process of providing information on the concentration of glucosamine or mannosamine in the blood sample used to predict the therapeutic effects of atypical stem cell transplantation on the subject of atypical stem cell transplantation andPrediction of therapeutic effects of atopic dermatitisDiagram